Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inari Medical, Inc. (NARI)
NASDAQ:NARI
Inari Medical (NARI) Stock Price & Analysis
286 Followers
NARI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$37.92 - $71.85
Previous Close$38.64
Volume796.79K
Average Volume (3M)1.19M
Market Cap
$2.24B
Enterprise Value$1.92B
Total Cash (Recent Filing)$351.30M
Total Debt (Recent Filing)$32.26M
Price to Earnings (P/E)-1211.3
Beta0.96
Next Earnings
Apr 30, 2024EPS Estimate
-$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding57,960,555
10 Day Avg. Volume863,293
30 Day Avg. Volume1,190,269
Standard Deviation0.13
R-Squared0.11
Alpha-0.00144
Financial Highlights & Ratios
Price to Book (P/B)22.73
Price to Sales (P/S)5.85
Price to Cash Flow (P/CF)46.30
P/FCF Ratio45.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.09
Enterprise Value/Gross Profit5.67
Enterprise Value/Ebitda173.29
Forecast
1Y Price Target
$71.11Price Target Upside84.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Inari Medical News
Bulls Say, Bears Say
Bulls Say
Financial OutlookAnalyst reiterates a Buy rating with a bullish price objective, signaling confidence in NARI's stock growth potential and viewing recent share price decreases as a buying opportunity.
Leadership ChangeTim Benner brings extensive operational and strategic experience from large global companies to his new role as SVP of Sales at NARI, promising to enhance the company's strategic move to scale internationally.
Product And Market ExpansionNARI, a dominant force in the US venous thromboembolism market, is poised for continued growth driven by new product launches, the LimFlow acquisition, and international market penetration.
Bears Say
Earnings MissNARI's net loss per share of $0.08 was worse than consensus EPS estimate of $0.01 and the $0.04 EPS estimate.
Legal IssuesReceived a civil investigative demand (CID) from the DOJ, outcome cannot be accurately predicted.
Sales PerformanceUS venous sales growth slowed in Q4 with NARI's Q4 US VTE sales decelerating from 20%+ growth in the earlier quarters to 16% year-over-year growth.
---
Ownership Overview
22.78% Insiders
37.99% Mutual Funds
25.82% Other Institutional Investors
13.41% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NARI FAQ
What was Inari Medical, Inc.’s price range in the past 12 months?
Inari Medical, Inc. lowest stock price was $37.92 and its highest was $71.85 in the past 12 months.
What is Inari Medical, Inc.’s market cap?
Currently, no data Available
When is Inari Medical, Inc.’s upcoming earnings report date?
Inari Medical, Inc.’s upcoming earnings report date is Apr 30, 2024 which is in 10 days.
How were Inari Medical, Inc.’s earnings last quarter?
Inari Medical, Inc. released its earnings results on Feb 28, 2024. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of $0.006 by -$0.086.
Is Inari Medical, Inc. overvalued?
According to Wall Street analysts Inari Medical, Inc.’s price is currently Undervalued.
Does Inari Medical, Inc. pay dividends?
Inari Medical, Inc. does not currently pay dividends.
What is Inari Medical, Inc.’s EPS estimate?
Inari Medical, Inc.’s EPS estimate is -$0.16.
How many shares outstanding does Inari Medical, Inc. have?
Inari Medical, Inc. has 57,960,556 shares outstanding.
What happened to Inari Medical, Inc.’s price movement after its last earnings report?
Inari Medical, Inc. reported an EPS of -$0.08 in its last earnings report, missing expectations of $0.006. Following the earnings report the stock price went down -20.838%.
Which hedge fund is a major shareholder of Inari Medical, Inc.?
Among the largest hedge funds holding Inari Medical, Inc.’s share is Slate Path Capital LP. It holds Inari Medical, Inc.’s shares valued at 27M.
---
Inari Medical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$71.11 (84.03% Upside)
$71.11 (84.03% Upside)
Blogger Sentiment
Bullish
NARI Sentiment 83%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 373.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days <0.1%
Last 30 Days ▼ 5.3%
Last 30 Days ▼ 5.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.80%
12-Months-Change
Fundamentals
Return on Equity
-0.37%
Trailing 12-Months
Asset Growth
33.74%
Trailing 12-Months
Company Description
Inari Medical, Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States.
---
NARI Company Deck
---
NARI Earnings Call
Q4 2024
0:00 / 0:00
---
NARI Revenue Breakdown
96.48% VTE
3.52% Emerging Therapies
---
NARI Stock 12 Months Forecast
Average Price Target
$71.11
▲(84.03% Upside)
Technical Analysis
Best Analysts Covering NARI
1 Year
1 Year Success Rate
5/17 ratings generated profit
1 Year Average Return
-5.39%
reiterated a buy rating 2 months ago
Copying William Plovanic's trades and holding each position for 1 Year would result in 29.41% of your transactions generating a profit, with an average return of -5.39% per trade.
---